-
1
-
-
1642588228
-
Pancreatic cancer
-
DOI 10.1016/S0140-6736(04)15841-8, PII S0140673604158418
-
Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet. 2004;363:1049-1057. (Pubitemid 38410779)
-
(2004)
Lancet
, vol.363
, Issue.9414
, pp. 1049-1057
-
-
Li, D.1
Xie, K.2
Wolff, R.3
Abbruzzese, J.L.4
-
2
-
-
0036884187
-
Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis
-
DOI 10.1053/gast.2002.37075
-
Greten FR, Weber CK, Greten TF, et al. Stat3 and NF-JB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology. 2002;123:2052-2063. (Pubitemid 35408327)
-
(2002)
Gastroenterology
, vol.123
, Issue.6
, pp. 2052-2063
-
-
Greten, F.R.1
Weber, C.K.2
Greten, T.F.3
Schneider, G.4
Wagner, M.5
Adler, G.6
Schmid, R.M.7
-
3
-
-
49349104165
-
Molecular targeted therapies for pancreatic cancer
-
Borja-Cacho D, Jensen EH, Saluja AK, et al. Molecular targeted therapies for pancreatic cancer. Am J Surg. 2008;196:430-441.
-
(2008)
Am J Surg.
, vol.196
, pp. 430-441
-
-
Borja-Cacho, D.1
Jensen, E.H.2
Saluja, A.K.3
-
4
-
-
0030846298
-
Tying it all together: Epigenetics, genetics, cell cycle, and cancer
-
DOI 10.1126/science.277.5334.1948
-
Baylin SB. Tying it all together: Epigenetics, genetics, cell cycle, and cancer. Science. 1997;277:1948-1949. (Pubitemid 27449125)
-
(1997)
Science
, vol.277
, Issue.5334
, pp. 1948-1949
-
-
Baylin, S.B.1
-
5
-
-
0030846212
-
Alterations in DNA methylation: A fundamental aspect of neoplasia
-
Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141-196. (Pubitemid 27435555)
-
(1997)
Advances in Cancer Research
, vol.72
, pp. 141-196
-
-
Baylin, S.B.1
Herman, J.G.2
Graff, J.R.3
Vertino, P.M.4
Issa, J.-P.5
-
6
-
-
0034075153
-
Hypermethylation of multiple genes in pancreatic adenocarcinoma
-
Ueki T, Toyota M, Sohn T, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res. 2000;60:1835-1839. (Pubitemid 30207640)
-
(2000)
Cancer Research
, vol.60
, Issue.7
, pp. 1835-1839
-
-
Ueki, T.1
Toyota, M.2
Sohn, T.3
Yeo, C.J.4
Issa, J.-P.J.5
Hruban, R.H.6
Goggins, M.7
-
7
-
-
33845627416
-
Acetylation and histone deacetylase inhibitors in cancer
-
Kortenhorst MS, Carducci MA, Shabbeer S. Acetylation and histone deacetylase inhibitors in cancer. Cell Oncol. 2006;28:191-222. (Pubitemid 44950093)
-
(2006)
Cellular Oncology
, vol.28
, Issue.5-6
, pp. 191-222
-
-
Kortenhorst, M.S.Q.1
Carducci, M.A.2
Shabbeer, S.3
-
8
-
-
34547911052
-
Chemistry of acetyl transfer by histone modifying enzymes: Structure, mechanism and implications for effector design
-
DOI 10.1038/sj.onc.1210619, PII 1210619
-
Hodawadekar SC, Marmorstein R. Chemistry of acetyl transfer by histone modifying enzymes: Structure, mechanism and implications for effector design. Oncogene. 2007;26:5528-5540. (Pubitemid 47255933)
-
(2007)
Oncogene
, vol.26
, Issue.37
, pp. 5528-5540
-
-
Hodawadekar, S.C.1
Marmorstein, R.2
-
9
-
-
0034610814
-
The language of covalent histone modifications
-
DOI 10.1038/47412
-
Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41-45. (Pubitemid 30038513)
-
(2000)
Nature
, vol.403
, Issue.6765
, pp. 41-45
-
-
Strahl, B.D.1
Allis, C.D.2
-
10
-
-
0141744707
-
Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects
-
DOI 10.1091/mbc.E03-01-0860
-
Cimini D, Mattiuzzo M, Torosantucci L, et al. Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects. Mol Biol Cell. 2003;14:3821-3833. (Pubitemid 37151628)
-
(2003)
Molecular Biology of the Cell
, vol.14
, Issue.9
, pp. 3821-3833
-
-
Cimini, D.1
Mattiuzzo, M.2
Torosantucci, L.3
Degrassi, F.4
-
11
-
-
4344716951
-
Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors
-
DOI 10.1023/B:APPT.0000038036.31271.50
-
Facchetti F, Previdi S, Ballarini M, et al. Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors. Apoptosis. 2004;9:573-582. (Pubitemid 39158633)
-
(2004)
Apoptosis
, vol.9
, Issue.5
, pp. 573-582
-
-
Facchetti, F.1
Previdi, S.2
Ballarini, M.3
Minucci, S.4
Perego, P.5
Porta, C.A.M.L.6
-
12
-
-
85047699941
-
Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling
-
Deroanne CF, Bonjean K, Servotte S, et al. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene. 2002;21:427Y436.
-
(2002)
Oncogene.
, vol.21
-
-
Deroanne, C.F.1
Bonjean, K.2
Servotte, S.3
-
13
-
-
34547101441
-
Gemcitabine-based combinations for inoperable pancreatic cancer: Have we made real progress? A meta-analysis of 20 phase 3 trials
-
DOI 10.1002/cncr.22809
-
Bria E, Milella M, Gelibter A, et al. Gemcitabine-based combinations for inoperable pancreatic cancer: Have we made real progress? A meta-analysis of 20 phase 3 trials. Cancer. 2007;110:525-533. (Pubitemid 47106140)
-
(2007)
Cancer
, vol.110
, Issue.3
, pp. 525-533
-
-
Bria, E.1
Milella, M.2
Gelibter, A.3
Cuppone, F.4
Pino, M.S.5
Ruggeri, E.M.6
Carlini, P.7
Nistico, C.8
Terzoli, E.9
Cognetti, F.10
Giannarelli, D.11
-
14
-
-
34247188535
-
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer
-
Sultana A, Smith CT, Cunningham D, et al. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol. 2007;25:2607Y2615.
-
(2007)
J Clin Oncol.
, vol.25
-
-
Sultana, A.1
Smith, C.T.2
Cunningham, D.3
-
15
-
-
42349093032
-
Meta-analysis of randomized trials: Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
-
Heinemann V, Boeck S, Hinke A, et al. Meta-analysis of randomized trials: Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer. BMC Cancer. 2008;8:82.
-
(2008)
BMC Cancer.
, vol.8
, pp. 82
-
-
Heinemann, V.1
Boeck, S.2
Hinke, A.3
-
16
-
-
77956258890
-
Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents
-
Frampton GA, Lazcano EA, Li H, et al. Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents. Lab Invest. 2010;90:1325-1338
-
(2010)
Lab Invest.
, vol.90
, pp. 1325-1338
-
-
Frampton, G.A.1
Lazcano, E.A.2
Li, H.3
-
17
-
-
33646533106
-
SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines
-
Ryu JK, Lee WJ, Lee KH, et al. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines. Cancer Lett. 2006;237:143-154.
-
(2006)
Cancer Lett.
, vol.237
, pp. 143-154
-
-
Ryu, J.K.1
Lee, W.J.2
Lee, K.H.3
-
18
-
-
33744749272
-
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation
-
Piacentini P, Donadelli M, Costanzo C, et al. Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. Virchows Arch. 2006;448:797Y804.
-
(2006)
Virchows Arch.
, vol.448
-
-
Piacentini, P.1
Donadelli, M.2
Costanzo, C.3
-
19
-
-
33846257239
-
Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells
-
DOI 10.1158/1535-7163.MCT-06-0419
-
Lee JH, Park JH, Jung Y, et al. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells. Mol Cancer Ther. 2006;5:3085-3095. (Pubitemid 46092050)
-
(2006)
Molecular Cancer Therapeutics
, vol.5
, Issue.12
, pp. 3085-3095
-
-
Lee, J.-H.1
Park, J.-H.2
Jung, Y.3
Kim, J.-H.4
Jong, H.-S.5
Kim, T.-Y.6
Bang, Y.-J.7
-
20
-
-
0242610850
-
Inhibition of Histone Deacetylase Increases Cytotoxicity to Anticancer Drugs Targeting DNA
-
Kim MS, Blake M, Baek JH, et al. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res. 2003;63:7291-7300. (Pubitemid 37413470)
-
(2003)
Cancer Research
, vol.63
, Issue.21
, pp. 7291-7300
-
-
Kim, M.S.1
Blake, M.2
Baek, J.H.3
Kohlhagen, G.4
Pommier, Y.5
Carrier, F.6
-
21
-
-
11144356134
-
The Histone Deacetylase Inhibitor MS-275 Interacts Synergistically with Fludarabine to Induce Apoptosis in Human Leukemia Cells
-
DOI 10.1158/0008-5472.CAN-03-2631
-
Maggio SC, Rosato RR, Kramer LB, et al. The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells. Cancer Res. 2004;64:2590-2600. (Pubitemid 38523917)
-
(2004)
Cancer Research
, vol.64
, Issue.7
, pp. 2590-2600
-
-
Maggio, S.C.1
Rosato, R.R.2
Kramer, L.B.3
Dai, Y.4
Rahmani, M.5
Paik, D.S.6
Czarnik, A.C.7
Payne, S.G.8
Spiegel, S.9
Grant, S.10
-
22
-
-
24344498688
-
Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer
-
DOI 10.1016/j.surg.2005.06.016, PII S0039606005003107
-
Rundall BK, Denlinger CE, Jones DR. Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in nonYsmall cell lung cancer. Surgery. 2005;138:360-367. (Pubitemid 41253822)
-
(2005)
Surgery
, vol.138
, Issue.2
, pp. 360-367
-
-
Rundall, B.K.1
Denlinger, C.E.2
Jones, D.R.3
-
23
-
-
33750998178
-
Activation of NF-κB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: Its implication for resistance to apoptosis
-
DOI 10.1038/sj.cdd.4401915, PII 4401915
-
Kim YK, Lee EK, Kang JK, et al. Activation of NF-JB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: Its implication for resistance to apoptosis. Cell Death Differ. 2006;13:2033-2041. (Pubitemid 44742686)
-
(2006)
Cell Death and Differentiation
, vol.13
, Issue.12
, pp. 2033-2041
-
-
Kim, Y.K.1
Lee, E.K.2
Kang, J.K.3
Kim, J.A.4
You, J.-S.5
Park, J.H.6
Seo, D.-W.7
Hwang, J.W.8
Kim, S.-N.9
Lee, H.Y.10
Lee, H.W.11
Han, J.-W.12
-
24
-
-
2342613652
-
The proteasome: A suitable antineoplastic target
-
Adams J. The proteasome: A suitable antineoplastic target. Nat Rev Cancer. 2004;4:349-360. (Pubitemid 38579481)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.5
, pp. 349-360
-
-
Adams, J.1
-
25
-
-
33747874802
-
Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells
-
DOI 10.1016/j.bbrc.2006.07.185, PII S0006291X0601638X
-
Bai J, Demirjian A, Sui J, et al. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. Biochem Biophys Res Commun. 2006; 348:1245-1253. (Pubitemid 44291339)
-
(2006)
Biochemical and Biophysical Research Communications
, vol.348
, Issue.4
, pp. 1245-1253
-
-
Bai, J.1
Demirjian, A.2
Sui, J.3
Marasco, W.4
Callery, M.P.5
-
26
-
-
0034665124
-
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
-
Butler LM, Agus DB, Scher HI, et al. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res. 2000;60:5165-5170.
-
(2000)
Cancer Res.
, vol.60
, pp. 5165-5170
-
-
Butler, L.M.1
Agus, D.B.2
Scher, H.I.3
-
27
-
-
33847372445
-
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: Effects on gene expression and growth of glioma cells in vitro and in vivo
-
DOI 10.1158/1078-0432.CCR-06-1261
-
Yin D, Ong JM, Hu J, et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: Effects on gene expression and growth of glioma cells in vitro and in vivo. Clin Cancer Res. 2007;13:1045-1052. (Pubitemid 46340384)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.3
, pp. 1045-1052
-
-
Yin, D.1
Ong, J.M.2
Hu, J.3
Desmond, J.C.4
Kawamata, N.5
Konda, B.M.6
Black, K.L.7
Koeffler, H.P.8
-
28
-
-
0037352170
-
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: A target for cancer chemotherapy
-
DOI 10.1038/sj.leu.2402824
-
Chang F, Lee JT, Navolanic PM, et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: A target for cancer chemotherapy. Leukemia. 2003;17:590-603. (Pubitemid 36395654)
-
(2003)
Leukemia
, vol.17
, Issue.3
, pp. 590-603
-
-
Chang, F.1
Lee, J.T.2
Navolanic, P.M.3
Steelman, L.S.4
Shelton, J.G.5
Blalock, W.L.6
Franklin, R.A.7
McCubrey, J.A.8
-
29
-
-
24944582402
-
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects
-
DOI 10.1158/0008-5472.CAN-05-0121
-
Maffucci T, Piccolo E, Cumashi A, et al. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Cancer Res. 2005;65: 8339-8349. (Pubitemid 41330599)
-
(2005)
Cancer Research
, vol.65
, Issue.18
, pp. 8339-8349
-
-
Maffucci, T.1
Piccolo, E.2
Cumashi, A.3
Iezzi, M.4
Riley, A.M.5
Saiardi, A.6
Godage, H.Y.7
Rossi, C.8
Broggini, M.9
Iacobelli, S.10
Potter, B.V.L.11
Innocenti, P.12
Falasca, M.13
-
30
-
-
0041338049
-
Inhibition of the phosphatidylinositol 3¶-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo
-
Bondar VM, Sweeney-Gotsch B, Andreeff M, et al. Inhibition of the phosphatidylinositol 3¶-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol Cancer Ther. 2002;1:989-997.
-
(2002)
Mol Cancer Ther.
, vol.1
, pp. 989-997
-
-
Bondar, V.M.1
Sweeney-Gotsch, B.2
Andreeff, M.3
-
31
-
-
0035992417
-
Inhibition of nuclear factor κB activation in PC3 cells by genistein is mediated via Akt signaling pathway
-
Li Y, Sarkar FH. Inhibition of nuclear factor JB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res. 2002;8:2369-2377. (Pubitemid 34753612)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.7
, pp. 2369-2377
-
-
Li, Y.1
Sarkar, F.H.2
-
32
-
-
3042642131
-
Inactivation of Akt and NF-κB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells
-
Rahman KM, Li Y, Sarkar FH. Inactivation of Akt and NF-JB play important roles during indole-3-carbinolYinduced apoptosis in breast cancer cells. Nutr Cancer. 2004;48:84-94. (Pubitemid 38823550)
-
(2004)
Nutrition and Cancer
, vol.48
, Issue.1
, pp. 84-94
-
-
Rahman, K.M.W.1
Li, Y.2
Sarkar, F.H.3
-
33
-
-
36849075271
-
Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer
-
DOI 10.1016/j.canlet.2007.09.015, PII S030438350700448X
-
Lee SH, Ryu JK, Lee KY, et al. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett. 2008;259:39-49. (Pubitemid 350235089)
-
(2008)
Cancer Letters
, vol.259
, Issue.1
, pp. 39-49
-
-
Lee, S.H.1
Ryu, J.K.2
Lee, K.-Y.3
Woo, S.M.4
Park, J.K.5
Yoo, J.W.6
Kim, Y.-T.7
Yoon, Y.B.8
-
34
-
-
0029846602
-
Association of bcl-2, bax, bcl-xL and interleukin-1 A-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia
-
Stoetzer OJ, Nussler V, Darsow M, et al. Association of bcl-2, bax, bcl-xL and interleukin-1 A-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. Leukemia. 1996;10(suppl 3):S18YS22.
-
(1996)
Leukemia.
, vol.10
, Issue.SUPPL. 3
-
-
Stoetzer, O.J.1
Nussler, V.2
Darsow, M.3
-
35
-
-
0031032294
-
Bcl-2 and Bcl-X(L) antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents
-
Decaudin D, Geley S, Hirsch T, et al. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 1997;57:62-67. (Pubitemid 27020331)
-
(1997)
Cancer Research
, vol.57
, Issue.1
, pp. 62-67
-
-
Decaudin, D.1
Geley, S.2
Hirsch, T.3
Castedo, M.4
Marchetti, P.5
Macho, A.6
Kofler, R.7
Kroemer, G.8
-
36
-
-
0031595523
-
Bcl-x(L) is expressed in ovarian carcinoma and modulates chemotherapy- induced apoptosis
-
DOI 10.1006/gyno.1998.5125
-
Liu JR, Fletcher B, Page C, et al. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis. Gynecol Oncol. 1998;70:398-403. (Pubitemid 28473641)
-
(1998)
Gynecologic Oncology
, vol.70
, Issue.3
, pp. 398-403
-
-
Liu, J.R.1
Fletcher, B.2
Page, C.3
Hu, C.4
Nunez, G.5
Baker, V.6
|